Precision oncology in biliary tract cancer: the emerging role of liquid biopsy
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health
This publication has 96 references indexed in Scilit:
- Final Overall Survival Efficacy Results of Ivosidenib for Patients With Advanced Cholangiocarcinoma With IDH1 MutationJAMA Oncology, 2021
- Early and accurate detection of cholangiocarcinoma in patients with primary sclerosing cholangitis by methylation markers in bileHepatology, 2021
- Comparative Genomic Analysis of Intrahepatic Cholangiocarcinoma: Biopsy Type, Ancestry, and Testing PatternsThe Oncologist, 2021
- Comprehensive genomic landscape and precision therapeutic approach in biliary tract cancersInternational Journal of Cancer, 2020
- MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to BedsideTargeted Oncology, 2020
- Modulation of Biliary Cancer Chemo‐Resistance Through MicroRNA‐Mediated Rewiring of the Expansion of CD133+ CellsHepatology, 2019
- A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancerInternational Journal of Cancer, 2019
- Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinomaTumor Biology, 2016
- Quantification of Circulating Free DNA as a Diagnostic Marker in Gall Bladder CancerPathology and Oncology Research, 2016
- Circulating tumor cells are associated with poor overall survival in patients with cholangiocarcinomaHepatology, 2015